Securing Leadership in Biotechnology & Advanced Biomanufacturing

The Advanced Regenerative Manufacturing Institute (ARMI) is a Department of Defense-sponsored Manufacturing Innovation Institute, advancing the U.S. bioeconomy by enabling scalable, secure, and cost-effective production of regenerative medicine technologies. Through its program BioFabUSA, ARMI is accelerating the development of critical biotechnologies and building a domestic ecosystem for advanced biomanufacturing that supports national security, health resilience, and economic growth.

BiofabUSA

BioFabUSA, a public-private partnership with more than 170 members across industry, academia, and government, is driving technical and strategic leadership in the development and manufacturing of cell, tissue, and organ-based products. The institute’s work strengthens domestic supply chains, supports dual-use technology development, and prepares a skilled workforce to meet the demands of a growing, globally competitive bioeconomy.

ARMI BioIndustries

ARMI BioIndustries is the development, manufacturing, and commercialization arm of the Advanced Regenerative Manufacturing Institute (ARMI). It provides full-service support to advance regenerative medicine technologies from concept to production—offering the infrastructure, expertise, and capabilities needed to bring innovative biomanufacturing solutions to market.

NextFab

NextFab is the first Foundry for American Biotechnology, established to strengthen the nation’s health security and accelerate biotechnology innovation. Its mission is to support the development of technologies that help the United States prepare for and respond to health-related threats, improve everyday medical care, and expand domestic capacity for advanced biomanufacturing.

BioFabUSA Membership

As an ARMI | BioFabUSA member, your organization becomes part of a national network driving the future of regenerative medicine and advanced manufacturing.
Members benefit from the collective expertise and capabilities of partners across industry, academia, government, and nonprofits. Together, we are building the technologies, standards, and workforce needed to transition tissue engineering and regenerative medicine from research to scalable, commercially viable solutions.

Membership provides opportunities to collaborate, access shared resources, and stay at the forefront of innovation in a field critical to U.S. health, economic, and national security priorities.

News

Events

  • Automation Fair® 2026

    Boston, MA Boston, MA, United States

    ARMI plans to participate in Automation Fair® 2026, Rockwell Automation’s premier industrial operations event, bringing together manufacturing leaders, technology innovators, and automation experts to explore the future of smart manufacturing.

  • JPM Week 2027 | Connect with ARMI in San Francisco

    San Francisco CA, United States

    ARMI | BioFabUSA is planning to participate in JPM Week 2027, January 11–14, in San Francisco. Connect with our team to explore opportunities for collaboration, advanced biomanufacturing, and commercialization. Contact events@armiusa.org to inquire about meeting during the week.

  • Advanced Therapies Week 2027

    San Diego, CA CA, United States

    ARMI | BioFabUSA is proud to partner with Phacilitate for Advanced Therapies Week 2027, January 18–21 in San Diego, California. Connect with industry leaders, innovators, and investors exploring manufacturing readiness, scale-up, and commercialization of next-generation biotherapeutics.

“There are hurdles that need to be overcome with tissue and organs for human transplant, and sometimes the traditional connection between industry and academia can be slow going. ARMI | BioFabUSA can accelerate this.”

David Brafman

Associate Professor at Arizona State University

ARMI

Initiatives

Learn more about work underway to build the biofabrication ecosystem and accelerate the science of regenerative medicine.